Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Dienstmann

Showing results (41-50 of 176) with videos related to

Pageof 18
Sort By:
Cancer Discovery|November 5, 2014
Social interactomes for enabling research communitiesJustin Guinney, Rodrigo Dienstmann, Charles Ferté, et al.
Drug Safety|December 6, 2011
Benefit-risk assessment of bevacizumab in the treatment of breast cancerRodrigo Dienstmann, Felipe Ades, Kamal S Saini, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 17, 2015
Stepwise group sparse regression (SGSR): gene-set-based pharmacogenomic predictive models with stepwise selection of functional priorsIn Sock Jang, Rodrigo Dienstmann, Adam A Margolin, et al.
Breast Cancer Research and Treatment|November 21, 2025
The promise of ctDNA-based, molecularly-driven early switch therapy from PADA-1 to SERENA-6Leandro Jonata Carvalho Oliveira, Max Senna Mano, Carlos Barrios, et al.
Cancer Treatment Reviews|April 1, 2023
Comprehensive evaluation of surrogate endpoints to predict overall survival in trials with PD1/PD-L1 immune checkpoint inhibitors plus chemotherapyGuillermo Villacampa, Pablo Cresta Morgado, Victor Navarro, et al.
Cancer Discovery|February 7, 2015
Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumorsRodrigo Dienstmann, In Sock Jang, Brian Bot, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 26, 2023
Precision medicine in Thoracic Oncology: understanding disparities to tackle inequities in accessFlávia Amaral Duarte, Pedro Nazareth Aguiar Junior, Rodrigo Dienstmann, et al.
Nature Reviews. Cancer|January 5, 2017
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancerRodrigo Dienstmann, Louis Vermeulen, Justin Guinney, et al.
Nature Reviews. Cancer|March 24, 2017
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancerRodrigo Dienstmann, Louis Vermeulen, Justin Guinney, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 17, 2025
Global Oncology: Tackling Disparities and Promoting Innovations in Low- and Middle-Income CountriesRegina Barragan-Carillo, Fredrick Chite Asirwa, Rodrigo Dienstmann, et al.
Pageof 18

Showing results (41-50 of 176) with videos related to

Sort By:
Pageof 18
Cancer Discovery|November 5, 2014
Social interactomes for enabling research communitiesJustin Guinney, Rodrigo Dienstmann, Charles Ferté, et al.
Drug Safety|December 6, 2011
Benefit-risk assessment of bevacizumab in the treatment of breast cancerRodrigo Dienstmann, Felipe Ades, Kamal S Saini, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 17, 2015
Stepwise group sparse regression (SGSR): gene-set-based pharmacogenomic predictive models with stepwise selection of functional priorsIn Sock Jang, Rodrigo Dienstmann, Adam A Margolin, et al.
Breast Cancer Research and Treatment|November 21, 2025
The promise of ctDNA-based, molecularly-driven early switch therapy from PADA-1 to SERENA-6Leandro Jonata Carvalho Oliveira, Max Senna Mano, Carlos Barrios, et al.
Cancer Treatment Reviews|April 1, 2023
Comprehensive evaluation of surrogate endpoints to predict overall survival in trials with PD1/PD-L1 immune checkpoint inhibitors plus chemotherapyGuillermo Villacampa, Pablo Cresta Morgado, Victor Navarro, et al.
Cancer Discovery|February 7, 2015
Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumorsRodrigo Dienstmann, In Sock Jang, Brian Bot, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 26, 2023
Precision medicine in Thoracic Oncology: understanding disparities to tackle inequities in accessFlávia Amaral Duarte, Pedro Nazareth Aguiar Junior, Rodrigo Dienstmann, et al.
Nature Reviews. Cancer|January 5, 2017
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancerRodrigo Dienstmann, Louis Vermeulen, Justin Guinney, et al.
Nature Reviews. Cancer|March 24, 2017
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancerRodrigo Dienstmann, Louis Vermeulen, Justin Guinney, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 17, 2025
Global Oncology: Tackling Disparities and Promoting Innovations in Low- and Middle-Income CountriesRegina Barragan-Carillo, Fredrick Chite Asirwa, Rodrigo Dienstmann, et al.
Pageof 18